SOURCE: Lifeline Biotechnologies, Inc.

August 21, 2006 08:31 ET

Lifeline Biotechnologies, Inc. Acquires Minority Interest in TrendSetter Solar Products, Inc. Valued at $600,000

RENO, NV -- (MARKET WIRE) -- August 21, 2006 -- Lifeline Biotechnologies, Inc. (PINKSHEETS: LBTN) announced today that it has acquired a minority interest in TrendSetter Solar Products, Inc. (PINKSHEETS: TSSP), a quality manufacturer of state-of-the-art, solar hot water heating and storage systems in the United States.

Lifeline received approximately 8.3 million shares of TrendSetter Industries which represents more than $600,000 in total value which will be added to the company's balance sheet. The acquisition of TrendSetter is part of Lifeline's strategy to increase shareholder value by improving its asset valuation and issuing dividends to its shareholders.

Lifeline recently announced that all shareholders of record will receive a stock dividend in Solos Endoscopy (SLSE) shares payable on September 29, 2006.

"This acquisition of a minority interest in TrendSetter Solar Products, Inc. is another major step in the execution of our diversification strategy. TrendSetter is an exciting, environmentally friendly company with a unique product that is becoming more necessary every day," stated Jim Holmes, CEO of Lifeline Biotechnologies, Inc.

TrendSetter Solar Products' solar hot water systems and storage tanks are uniquely positioned to serve the residential and commercial market because the Company offers a full range of systems that are rated to take advantage of the new federal energy tax credit program. Tax Credits ( are available at a 30% credit for up to $2,000 for the purchase and installation of solar electric and solar water heating systems. In addition, yearly operating costs are low because solar electricity needs very little maintenance, very few spare parts, and no fuel. Information about TrendSetter can be obtained from their website at:

About Lifeline Biotechnologies, Inc.:

Lifeline Biotechnologies develops and acquires undervalued companies which have innovative technology in the medical, nutraceutical, and energy industries, to increase the growth of the Company. Lifeline Biotechnologies continues to seek out and capitalize on emerging technologies that will change the medical, nutraceutical, and energy community.

More information is available at the company's website:

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Contact Information

  • Contact:
    Lifeline Biotechnologies, Inc.
    Investor Relations